Skip to content

News

OCRA’s Statement on SCOTUS and the Affordable Care Act (ACA)

OCRA’s Statement on SCOTUS and the Affordable Care Act (ACA)

The Supreme Court is poised to consider California v. Texas, which will decide the fate of the Affordable Care Act (ACA) — their decision could threaten health coverage for millions of people with pre-existing conditions, including ovarian cancer.  OCRA is vigilantly monitoring this upcoming decision, and preparing strategies for addressing any outcomes that may threaten … Continued

Everything You Need to Know About Johanna’s Law and Reauthorization

Everything You Need to Know About Johanna’s Law and Reauthorization

An important victory for the ovarian cancer community came in 2006 when Congress passed Johanna’s Law.  What is Johanna’s Law? Also known as The Gynecologic Cancer Education and Awareness Act, the legislation supports a variety of programs, research projects and activities at Centers for Disease Control and Prevention (CDC) aimed at educating healthcare providers and … Continued

Action Alert: Tell Congress to Support Full Funding for OCRP

Action Alert: Tell Congress to Support Full Funding for OCRP

The Ovarian Cancer Research Program (OCRP) is a cutting-edge program housed within the Department of Defense. Despite a history of successful breakthroughs, the program has long been drastically underfunded. The House and Senate are currently working to determine funding levels for programs in Fiscal Year 2021. Urge your Members of Congress to support full funding … Continued

OCRA Supports The CLINICAL TREATMENT Act (H.R. 913)

OCRA Supports The CLINICAL TREATMENT Act (H.R. 913)

For many ovarian cancer patients, clinical trials offer a promising avenue for expanding treatment options and extending survival. Unfortunately, participation comes at a steep financial cost that is often prohibitive – even for patients with health insurance. Over 20 percent of cancer patients report out-of-pocket costs as a major barrier to joining a trial.  The costs of … Continued

Connecting Survivors to the Science | Meet a Research Advocate

Connecting Survivors to the Science | Meet a Research Advocate

To speak with Kimberly Richardson is to feel an instant camaraderie with someone who exhibits both calm and conviction, thoughtfulness and frank talk. She has learned a lot in the past 20 years – running triathlons, running a nonprofit in Chicago focused on small business development, teaching urban sociology as an adjunct professor – and … Continued

Speaking Out for Those Who Can’t | Meet an Advocate Leader

Speaking Out for Those Who Can’t | Meet an Advocate Leader

In 2005, Denise Lobodinski’s sister Renee was diagnosed with ovarian cancer at the age of 47. That same year, their father was diagnosed with prostate cancer. But her father’s doctor told Denise’s mother, “Don’t worry about your husband. Worry about your daughter.” In fifteen years, Denise feels like very little has changed in terms of … Continued

Action Alert: Help Push Forward Treatments in the Time of COVID-19

Action Alert: Help Push Forward Treatments in the Time of COVID-19

The novel coronavirus pandemic has impacted the healthcare system on every level. Right now, OCRA is working alongside several cancer advocacy groups to ensure government agencies are aware of COVID-19’s real-life impact on cancer patients. If you’re currently undergoing treatment for ovarian cancer, please take a moment to complete the form below. Sharing your experience … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.